Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹203Cr
Rev Gr TTM
Revenue Growth TTM
17.51%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CHEMBOND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 29.8 | 16.3 | 1.7 | 3.6 | -61.4 | -59.3 | -55.6 | -53.7 | 10.9 | 24.7 | 16.0 | 18.6 |
| 109 | 105 | 98 | 100 | 44 | 43 | 47 | 49 | 49 | 54 | 54 | 59 |
Operating Profit Operating ProfitCr |
| 10.8 | 7.9 | 13.0 | 12.4 | 6.5 | 7.4 | 5.6 | 7.1 | 6.9 | 6.0 | 7.0 | 6.6 |
Other Income Other IncomeCr | 2 | 3 | 9 | 4 | 1 | 2 | 5 | 0 | 2 | 3 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 13 | 11 | 22 | 16 | 3 | 5 | 7 | 3 | 4 | 5 | 3 | 3 |
| 3 | 2 | 7 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | -1 | 1 |
|
Growth YoY PAT Growth YoY% | 380.1 | 755.2 | 97.8 | 62.1 | -85.1 | -46.7 | -59.1 | -76.0 | 122.5 | -14.7 | -39.1 | -50.9 |
| 8.3 | 7.7 | 13.7 | 11.8 | 3.2 | 10.1 | 12.6 | 6.1 | 6.4 | 6.9 | 6.6 | 2.5 |
| 5.0 | 4.3 | 7.5 | 6.6 | 0.7 | 2.3 | 3.1 | 1.6 | 1.6 | 3.0 | 2.9 | 1.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -9.7 | 7.3 | 12.6 | -8.0 | -11.0 | 2.4 | 27.2 | 26.2 | -59.5 | 12.9 | 14.5 |
| 274 | 260 | 274 | 305 | 276 | 258 | 256 | 332 | 406 | 172 | 188 | 215 |
Operating Profit Operating ProfitCr |
| 8.9 | 4.2 | 5.8 | 6.9 | 8.5 | 3.7 | 6.6 | 4.9 | 7.9 | 3.5 | 6.8 | 6.6 |
Other Income Other IncomeCr | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 9 | 4 |
Interest Expense Interest ExpenseCr | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
Depreciation DepreciationCr | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 3 |
| 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 16 |
| 6 | 38 | 7 | 4 | 5 | 5 | 8 | 7 | 9 | 6 | 2 | 3 |
|
| | 986.6 | -85.4 | 3.1 | -15.8 | -84.5 | 561.5 | -31.5 | 79.9 | -55.6 | 57.1 | -27.3 |
| 4.8 | 57.7 | 7.9 | 7.2 | 6.6 | 1.1 | 7.4 | 4.0 | 5.7 | 6.3 | 8.7 | 5.5 |
| 6.1 | 75.6 | 11.1 | 10.7 | 8.5 | 0.9 | 9.9 | 6.8 | 12.3 | 5.5 | 8.6 | 8.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 137 | 149 | 155 |
Current Liabilities Current LiabilitiesCr | 88 | 64 | 66 | 72 | 55 | 46 | 58 | 54 | 77 | 48 | 46 | 50 |
Non Current Liabilities Non Current LiabilitiesCr | 7 | 4 | 7 | 3 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 141 | 171 | 196 | 153 | 169 | 162 | 183 | 194 | 219 | 102 | 101 | 109 |
Non Current Assets Non Current AssetsCr | 62 | 118 | 125 | 172 | 153 | 160 | 171 | 167 | 183 | 89 | 100 | 102 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 24 | -27 | 5 | -12 | -12 | 24 | 25 | -10 | 1 | 94 | 19 |
Investing Cash Flow Investing Cash FlowCr | -3 | 52 | 0 | 19 | 14 | -12 | -11 | -2 | 1 | -89 | -8 |
Financing Cash Flow Financing Cash FlowCr | -18 | -24 | -3 | -4 | -6 | -11 | -2 | -4 | -2 | -5 | -9 |
|
Free Cash Flow Free Cash FlowCr | 21 | -24 | -1 | -75 | -19 | 7 | 22 | -14 | -12 | 90 | 16 |
| 168.1 | -17.1 | 21.4 | -52.1 | -61.5 | 766.9 | 122.5 | -74.9 | 3.8 | 844.0 | 110.9 |
CFO To EBITDA CFO To EBITDA% | 90.9 | -236.9 | 28.9 | -54.5 | -47.9 | 236.9 | 137.6 | -61.3 | 2.7 | 1,489.5 | 143.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 228 | 279 | 247 | 412 | 430 | 198 | 255 | 241 | 341 | 644 | 680 |
Price To Earnings Price To Earnings | 19.9 | 1.8 | 12.8 | 18.8 | 24.8 | 106.0 | 12.6 | 17.3 | 13.6 | 57.6 | 38.7 |
Price To Sales Price To Sales | 0.8 | 1.0 | 0.8 | 1.3 | 1.4 | 0.7 | 0.9 | 0.7 | 0.8 | 3.6 | 3.4 |
Price To Book Price To Book | 2.4 | 1.4 | 1.1 | 1.7 | 1.6 | 0.7 | 0.9 | 0.8 | 1.1 | 4.5 | 4.3 |
| 8.8 | 24.2 | 14.3 | 17.9 | 16.6 | 18.8 | 12.8 | 13.0 | 9.1 | 100.7 | 49.2 |
Profitability Ratios Profitability Ratios |
| 38.2 | 33.2 | 35.2 | 36.2 | 44.4 | 47.1 | 47.8 | 41.6 | 42.1 | 40.2 | 42.3 |
| 8.9 | 4.2 | 5.8 | 6.9 | 8.5 | 3.7 | 6.6 | 4.9 | 7.9 | 3.5 | 6.8 |
| 4.8 | 57.7 | 7.9 | 7.2 | 6.6 | 1.1 | 7.4 | 4.0 | 5.7 | 6.3 | 8.7 |
| 20.3 | 90.5 | 13.1 | 11.3 | 9.4 | 3.2 | 9.8 | 7.0 | 10.7 | 11.6 | 12.7 |
| 15.1 | 75.8 | 9.9 | 9.5 | 7.6 | 1.1 | 7.0 | 4.6 | 7.8 | 7.8 | 11.3 |
| 7.1 | 54.2 | 7.1 | 7.3 | 6.2 | 1.0 | 5.8 | 3.9 | 6.3 | 5.8 | 8.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Chembond Material Technologies Limited (CMTL) is a leading specialty chemicals manufacturer in India with nearly five decades of industry experience. The company serves diverse sectors through its core business segments: **Water Technologies (WT), Construction Chemicals (CC), Material Technologies, Biotechnology (Biosciences), Adhesives & Sealants, and Distribution**. It has evolved from a startup into a major player in the Indian specialty chemicals space, with growing international presence and a strong focus on innovation, sustainability, and customer-centric solutions.
Through a strategic demerger effective April 1, 2024, the **Water Technologies and Construction Chemicals** businesses were transferred to a newly incorporated entity, **Chembond Chemicals Limited**, allowing for independent management, investment, and operational focus across different business lines. This structural change reflects CMTL’s intent to streamline growth, attract targeted investor interest, and enhance long-term value creation.
---
### **Core Business Segments**
#### **1. Water Technologies (WT)**
- A pioneer in India’s water treatment sector, WT provides integrated **Total Water Management (TWM)** solutions for industrial and commercial & industrial (C&I) clients.
- Offers a comprehensive portfolio covering:
- Raw water clarification
- Cooling and boiler water treatment
- Membrane treatment (including NSF-approved RO membranes and evaporator treatments)
- Wastewater treatment and bioremediation
- Automated online monitoring and AI-based remote control systems
- Solutions are tailored using system surveys, field expertise, and performance monitoring to improve **water-use efficiency**, enable **zero liquid discharge (ZLD)**, and support water recycling.
- Expanded distribution partnership with **MANN+HUMMEL’s Membrane Solutions** (via subsidiary Chembond Clean Water Technologies Ltd.) for advanced products like BIO-CEL® MBR, AQUADYN® UF, and MICRODYN spiral membranes.
- Recognized as **Frost & Sullivan’s “Indian Water Treatment Chemicals Company of the Year” (2020)**.
#### **2. Construction Chemicals (CC)**
- Provides specialized chemical solutions for infrastructure and building projects including highways, bridges, airports, railways, and commercial constructions.
- Product range includes admixtures, sealants, curing compounds, cementitious materials, and waterproofing agents.
- Supported by:
- Two **company-owned manufacturing plants**
- A **network of toll blending facilities** across India
- A central **Application & Development Laboratory** in Gujarat, enabling innovation and quality assurance
- Achieved **12% revenue growth** in FY24 driven by demand from public infrastructure projects, including those under **NHAI, PWD, and Metro Rail**.
- Focus in FY25 is on **profitability, creditworthiness of customers, and team scaling** rather than aggressive top-line expansion.
#### **3. Material Technologies & Industrial Solutions**
- Delivers high-performance **metal treatment chemicals, industrial coatings, sealants, and engineering adhesives**.
- Key growth areas include:
- **Automotive sealants** with enhanced performance properties approved for production lines
- **Eco-friendly surface treatment solutions** for steel and coil industries
- Energy- and water-saving cleaners developed through focused R&D
- Secured supply agreements in the **white goods and cold forming industries**, with exports expanding into **African steel markets**.
- Developing **biobased polyamides** and advanced thermoplastics using renewable resources.
#### **4. Biosciences (Animal Health & Nutrition)**
- Operates in India’s fast-growing **animal healthcare market**, valued at ₹86 billion in 2024.
- Livestock (65%), companion animals (25%), and aquaculture (10%) are key market segments.
- Focuses on **feed additives**, including:
- Probiotics and prebiotics
- Enzymes
- Biosecurity solutions
- Farm management products
- Despite a challenging FY23 due to industry headwinds (bird flu, feed cost inflation), the division achieved:
- **67% growth in dairy nutrition**
- Successful launch of probiotics with improved delivery systems
- Expansion into northern and western India
- In-house R&D leverages submerged fermentation and downstream processing expertise.
#### **5. Chembond Calvatis (JV with Calvatis GmbH, Germany)**
- Provides hygiene and cleaning solutions for **food, beverage, dairy, hospitality, and institutional sectors**.
- Faced sales decline due to a major customer shifting to a centralized global vendor.
- Responding by:
- Expanding product lines for **laundry, kitchen, and housekeeping operations**
- Strengthening distribution network
- Diversifying into new industrial applications
- Expected to return to growth from **FY2024–25** onward.
---
### **Strategic Developments**
- **Demerger & Reorganization:** The separation of CC and WT into **Chembond Chemicals Limited** (incorporated Dec 2023) allows focused development of each segment, aligned with distinct risk profiles, competition dynamics, and investor appetites.
- **R&D Investment:** Plans to increase R&D spending to **5–10% of sales** to drive innovation, particularly in green chemistries, AI-enabled monitoring, and sustainable formulations.
- **Digital Transformation:** Actively deploying **AI-based remote monitoring and control systems** in water treatment to enhance service delivery and competitiveness.
- **Sustainability Focus:** Developing environmentally advantageous products and promoting water efficiency, reduced energy consumption, and circular economy principles across operations.
---
### **Operations & Infrastructure**
- **Manufacturing Plants**: Located in **Baddi, Dudhwada, Navi Mumbai, Pune, Ranipet, Tarapur**, and other strategic locations.
- All facilities adhere to **global best practices** in safety, health, and environmental standards.
- Strong **back-end infrastructure** includes:
- Regional offices
- Trained technical workforce
- Well-equipped R&D laboratories
- Robust supply chain and logistics
---
### **Leadership & Governance**
- **Mr. Sameer V. Shah** – Chairman & Managing Director (since 2012), Chemical Engineer; instrumental in driving growth in material technologies, biobased polyamides, and expanding core businesses.
- **Mrs. Padma V. Shah** – Promoter family member; contributed to organizational stability and administrative strength since inception.
- **Mr. Kamal Tandon** – Appointee Director; brings **38+ years of experience** from Oil & Gas and Petrochemical sectors, including leadership roles at **GAIL** and **ONGC Petro Additions Limited**.
---
### **Recent Performance Highlights**
| Segment | Key Developments (as of Jul 2025) |
|--------------------------|-----------------------------------|
| **Construction Chemicals** | 12% revenue growth; 32% YoY profit increase; strong government project wins |
| **Water Technologies** | Portfolio expansion in petrochemicals/refining; momentum in ZLD and reuse solutions |
| **Material Technologies** | New eco-friendly cleaners; automotive sealant approvals; African exports |
| **Biosciences** | Launched enhanced probiotics; dairy nutrition doubling in FY22; retail JV in Gujarat |
| **Chembond Calvatis** | Expanding into institutional hygiene; rebuilding after key customer loss |